Nuveen Select Tax-Free Income Portfolio
NYSE:NXP
14.56 (USD) • At close July 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 27.531 | 0.077 | -43.692 | 18.675 | 13.595 | 15.585 | 11.396 | 10.019 | 10.383 | 10.702 | 11.562 | 12.196 | 0 |
| Cost of Revenue
| 1.456 | -25.395 | -58.698 | 8.208 | 3.348 | 5.483 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 26.075 | 25.472 | 15.006 | 10.468 | 10.247 | 10.102 | 11.396 | 10.019 | 10.383 | 10.702 | 11.562 | 12.196 | 0 |
| Gross Profit Ratio
| 0.947 | 329.959 | -0.343 | 0.561 | 0.754 | 0.648 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.27 | 0.35 | 0.204 | 0.155 | 0.157 | 0.142 | 0.162 | 0.716 | 0.706 | 0.797 | 0.684 | 0.697 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.27 | 0.35 | 0.204 | 0.155 | 0.157 | 0.142 | 0.162 | 0.716 | 0.706 | 0.797 | 0.684 | 0.697 | 0 |
| Other Expenses
| 5.344 | -15.141 | 0.009 | 0.008 | 0.009 | 0.01 | 0.012 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| -5.344 | 0.376 | 0.214 | 0.164 | 0.166 | 0.152 | 0.174 | 8.873 | 4.235 | 13.932 | 10.782 | 7.228 | 0 |
| Operating Income
| 31.418 | 23.839 | 13.998 | 9.77 | 9.55 | 9.442 | 11.222 | 9.303 | 9.677 | 9.905 | 10.878 | 11.499 | 0 |
| Operating Income Ratio
| 1.141 | 308.801 | -0.32 | 0.523 | 0.702 | 0.606 | 0.985 | 0.929 | 0.932 | 0.926 | 0.941 | 0.943 | 0 |
| Total Other Income Expenses Net
| -0.02 | -24.138 | -58.129 | 8.742 | 3.878 | 5.991 | 0 | -7.894 | 4.574 | 12.43 | -10.332 | 7.924 | 0 |
| Income Before Tax
| 31.399 | -0.299 | -44.131 | 18.512 | 13.429 | 15.433 | 11.222 | 1.408 | 14.251 | 22.336 | 0.546 | 19.423 | 0 |
| Income Before Tax Ratio
| 1.141 | -3.876 | 1.01 | 0.991 | 0.988 | 0.99 | 0.985 | 0.141 | 1.373 | 2.087 | 0.047 | 1.593 | 0 |
| Income Tax Expense
| 0 | -24.142 | -58.129 | 8.742 | 3.878 | 5.991 | 0 | -7.894 | 4.208 | 10.132 | -10.566 | 7.924 | 0 |
| Net Income
| 31.399 | -0.299 | -44.131 | 18.512 | 13.429 | 15.433 | 11.222 | 1.408 | 14.251 | 22.336 | 0.546 | 19.423 | 0 |
| Net Income Ratio
| 1.141 | -3.876 | 1.01 | 0.991 | 0.988 | 0.99 | 0.985 | 0.141 | 1.373 | 2.087 | 0.047 | 1.593 | 0 |
| EPS
| 0.66 | -0.006 | -0.94 | 1.12 | 0.81 | 0.94 | 0.68 | 0.085 | 0.86 | 1.35 | 0.033 | 1.17 | 0 |
| EPS Diluted
| 0.66 | -0.006 | -0.94 | 1.12 | 0.81 | 0.94 | 0.67 | 0.085 | 0.86 | 1.35 | 0.033 | 1.17 | 0 |
| EBITDA
| 31.418 | -24.142 | -58.129 | 8.742 | 3.878 | 5.991 | 11.222 | -7.894 | 4.208 | 10.132 | -10.566 | 7.924 | 0 |
| EBITDA Ratio
| 1.141 | -312.734 | 1.33 | 0.468 | 0.285 | 0.384 | 0.985 | -0.788 | 0.405 | 0.947 | -0.914 | 0.65 | 0 |